0000920465-15-000082.txt : 20151223 0000920465-15-000082.hdr.sgml : 20151223 20151223164118 ACCESSION NUMBER: 0000920465-15-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151221 FILED AS OF DATE: 20151223 DATE AS OF CHANGE: 20151223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 151306231 4 1 wf-form4_145090686812879.xml FORM 4 X0306 4 2015-12-21 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001287235 TIDMARSH GEORGE F C/O LA JOLLA PHARMACEUTICAL COMPANY, 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 1 1 0 0 President, CEO & Secretary Stock Option (Right to Buy) 28.24 2015-12-21 4 A 0 289000 0 A 2025-12-21 Common Stock 289000.0 289000 D This option represents a right to purchase a total of 289,000 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on December 21, 2016, with the remaining 216,750 shares vesting monthly thereafter over the next three years. /s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh 2015-12-23